A detailed history of Us Bancorp \De\ transactions in Baxter International Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 117,329 shares of BAX stock, worth $4.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117,329
Previous 126,178 7.01%
Holding current value
$4.06 Million
Previous $4.22 Million 5.55%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$32.85 - $40.26 $290,689 - $356,260
-8,849 Reduced 7.01%
117,329 $4.45 Million
Q2 2024

Aug 06, 2024

SELL
$32.87 - $43.55 $399,403 - $529,176
-12,151 Reduced 8.78%
126,178 $4.22 Million
Q1 2024

May 07, 2024

SELL
$37.88 - $43.77 $216,370 - $250,014
-5,712 Reduced 3.97%
138,329 $5.91 Million
Q4 2023

Feb 09, 2024

SELL
$31.71 - $38.95 $150,590 - $184,973
-4,749 Reduced 3.19%
144,041 $5.57 Million
Q3 2023

Nov 03, 2023

SELL
$37.32 - $49.29 $543,006 - $717,169
-14,550 Reduced 8.91%
148,790 $5.62 Million
Q2 2023

Aug 09, 2023

SELL
$39.98 - $47.68 $228,405 - $272,395
-5,713 Reduced 3.38%
163,340 $7.44 Million
Q1 2023

May 09, 2023

SELL
$37.58 - $52.57 $475,387 - $665,010
-12,650 Reduced 6.96%
169,053 $6.86 Million
Q4 2022

Feb 13, 2023

BUY
$49.7 - $57.71 $1.11 Million - $1.29 Million
22,368 Added 14.04%
181,703 $9.26 Million
Q3 2022

Oct 27, 2022

SELL
$53.86 - $66.8 $1.44 Million - $1.78 Million
-26,648 Reduced 14.33%
159,335 $8.58 Million
Q2 2022

Aug 01, 2022

SELL
$63.83 - $80.0 $457,214 - $573,040
-7,163 Reduced 3.71%
185,983 $11.9 Million
Q1 2022

May 11, 2022

SELL
$76.85 - $89.45 $380,100 - $442,419
-4,946 Reduced 2.5%
193,146 $15 Million
Q4 2021

Feb 11, 2022

SELL
$74.57 - $87.19 $324,379 - $379,276
-4,350 Reduced 2.15%
198,092 $17 Million
Q3 2021

Nov 10, 2021

SELL
$73.77 - $83.61 $404,923 - $458,935
-5,489 Reduced 2.64%
202,442 $16.3 Million
Q2 2021

Aug 05, 2021

SELL
$80.5 - $88.01 $1.54 Million - $1.68 Million
-19,096 Reduced 8.41%
207,931 $16.7 Million
Q1 2021

Apr 28, 2021

SELL
$76.38 - $86.03 $1.35 Million - $1.52 Million
-17,631 Reduced 7.21%
227,027 $19.1 Million
Q4 2020

Feb 04, 2021

SELL
$75.39 - $82.36 $664,562 - $726,003
-8,815 Reduced 3.48%
244,658 $19.6 Million
Q3 2020

Nov 10, 2020

SELL
$78.33 - $90.73 $393,686 - $456,008
-5,026 Reduced 1.94%
253,473 $20.4 Million
Q2 2020

Aug 07, 2020

SELL
$78.66 - $94.14 $415,796 - $497,624
-5,286 Reduced 2.0%
258,499 $22.3 Million
Q1 2020

May 13, 2020

SELL
$71.57 - $93.3 $967,554 - $1.26 Million
-13,519 Reduced 4.88%
263,785 $21.4 Million
Q4 2019

Feb 04, 2020

SELL
$76.7 - $88.45 $4.47 Million - $5.15 Million
-58,231 Reduced 17.35%
277,304 $23.2 Million
Q3 2019

Nov 08, 2019

SELL
$81.4 - $89.78 $370,939 - $409,127
-4,557 Reduced 1.34%
335,535 $29.3 Million
Q2 2019

Aug 13, 2019

SELL
$73.44 - $82.41 $426,172 - $478,225
-5,803 Reduced 1.68%
340,092 $27.9 Million
Q1 2019

May 08, 2019

SELL
$64.48 - $81.31 $249,150 - $314,181
-3,864 Reduced 1.1%
345,895 $28.1 Million
Q4 2018

Feb 13, 2019

SELL
$61.45 - $77.8 $2.47 Million - $3.13 Million
-40,229 Reduced 10.32%
349,759 $23 Million
Q3 2018

Nov 01, 2018

SELL
$70.71 - $77.75 $58,265 - $64,066
-824 Reduced 0.21%
389,988 $30.1 Million
Q2 2018

Aug 08, 2018

BUY
$63.43 - $75.41 $62,097 - $73,826
979 Added 0.25%
390,812 $28.9 Million
Q1 2018

May 08, 2018

SELL
$62.56 - $72.26 $114,297 - $132,019
-1,827 Reduced 0.47%
389,833 $25.4 Million
Q4 2017

Feb 02, 2018

BUY
$61.45 - $66.05 $281,133 - $302,178
4,575 Added 1.18%
391,660 $25.3 Million
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $23 Million - $25 Million
387,085
387,085 $24.3 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.